GLP-1 R is designed to act on the glucagon-like peptide-1 (GLP-1) receptor, a key pathway involved in glucose metabolism and appetite control. By activating this receptor, it may support insulin secretion in response to elevated blood glucose levels, reduce glucagon release, and slow gastric emptying. These physiological effects can contribute to improved glycemic regulation and enhanced satiety. GLP-1 receptor agonists are widely studied for their role in metabolic health, weight management, and cardiovascular risk reduction in individuals with insulin resistance or type 2 diabetes.